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A 31p-NUCLEAR MAGNETIC 
RESONANCE STUDY OF 
INTERMITTENT WARM 
BLOOD CARDIOPLEGIA 
This study was designed to assess the effects of intermittent warm blood cardioplegia on 
myocardial energy metabolites, intracellular pH, and contractile function. The isolated 
blood-perfused pig hearts were divided into three groups. After 30 minutes of control 
perfusion, the hearts in group 1 (n = 10) received 90 minutes of continuous warm 
(37 ° C) blood cardioplegia; the hearts in group 2 (n = 9) received six 5-minute periods 
of warm blood cardioplegia, interrupted by six 10-minute pisodes of ischemia (37 ° C). 
The hearts were then reperfused for 30 minutes. The hearts in group 3 underwent 150 
minutes of control perfusion without cardioplegia or ischemic episodes. Phosphorus 
31-nuclear magnetic resonance spectra showed that a 10-minute interruption fwarm 
blood cardioplegia decreased phosphocreatine l vels and intracellular pH by approxi- 
mately 47% (p < 0.01) and 0.12 unit (p < 0.05), respectively, and increased inorganic 
phosphate levels by approximately 87%, whereas resumption of cardioplegia for 5 
minutes resulted in almost 100% recovery of phosphocreatine and inorganic phosphate 
levels and intracellular pH. More important, subsequent interruptions did not result in 
any cumulative changes in phosphocreatine l vel, inorganic phosphate level, or intra- 
cellular pH beyond those changes observed after the initial cardioplegic interruption. 
Moreover, during reperfusion there were no significant differences in adenosine 
triphosphate and phosphocreatine l vels among the three groups of hearts. Further- 
more, hearts from groups I and 2 showed comparable recovery of contractile function. 
These results indicate that six 10-minute interruptions and six 5-minute restorations of 
warm blood cardioplegia caused only mild and reversible changes in myocardial energy 
metabolites and intracellular pH and these changes were not cumulative. This study 
suggests that antegrade intermittent warm blood cardioplegia may provide as much 
myocardial protection as does antegrade continuous warm blood cardioplegia in the 
normal heart. (J THORAC CARDIOVASC SURG 1995;109:1155-63) 
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cally, be the optimal technique for heart protection 
because it aims to avoid myocardial ischemia and 
subsequent reperfusion injury. 1 In practice, contin-. 
uous infusion of warm blood cardioplegia may result 
in inadequate visualization of the operative field and[ 
make intracardiac manipulations difficult in some', 
circumstances, z Therefore surgical precision may 
necessitate discontinuation of cardioplegia for short 
intervals. 2 The interruptions of warm blood cardio-. 
plegia will impose repetitive ischemic episodes on 
the "diseased" myocardium. Although a short pe-- 
riod (<15 minutes) of ischemia is insufficient per se 
to cause severe myocardial injury, it is not clear 
whether recurrent ischemic episodes have a cumu- 
lative effect on myocardial metabolism and function, 
which may ultimately cause irreversible injury. 
Experimental results in this context are conflict- 
ing. Lange, Ware, and Kloner 3 found that short 
periods (5 and 15 minutes) of occlusion of the left 
1155 
1156 Tian et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
June 1995 
anterior descending coronary artery resulted in sig- 
nificant depression of contractile function in the 
canine heart. These alterations, however, were not 
cumulative after three repetitive coronary artery 
occlusions. Reimer and associates 4 reported that 
one 10-minute period of ischemia caused a 61% loss 
of myocardial adenosine triphosphate (ATP) and a 
41% loss of adenine nucleotides from the canine 
heart, whereas four 10-minute periods of ischemia 
did not cause further loss of ATP or adenine 
nucleotides. Other investigators have reported con- 
tradictory results, s'6 It must be noted that the 
myocardial ischemia in the aforementioned experi- 
ments was regional and simply induced by occlusion 
of a coronary artery; it was not initiated by infusion 
of a cardioplegic solution. The changes in myocar- 
dial high energy metabolites and intracellular pH, as 
well as contractile function during reflow, may be 
expected to be significantly different in the heart in 
which myocardial ischemia is induced by intermit- 
tent warm blood cardioplegia. 
The present study was done to determine the 
effects of intermittent warm blood cardioplegia on 
myocardial high energy phosphates, intracellular 
pH, and contractile function in the normal heart. 
The changes in myocardial energy metabolites 
(ATP, phosphocreatine, and inorganic phosphate) 
and intracellular pH were compared in pig hearts 
subjected either to 90 minutes of continuous warm 
blood cardioplegia or to six 5-minute periods of 
warm blood cardioplegia interrupted by six 10- 
minute periods of normothermic schemia. Because 
myocardial adenine nucleotides and energy charge 
are restored within 3 minutes of reperfusion and 
recovery of phosphocreatine takes place rapidly on 
reperfusion, 5 minutes of reflow of cardioplegic 
solution was chosen] A 10-minute interval of isch- 
emia was used to mimic the clinical situation. Myo- 
cardial energy metabolites and intracellular pH 
were monitored with the use of phosphorus 31- 
nuclear magnetic resonance (31p-NMR) spectros- 
copy because this technique is noninvasive and 
nondestructive and a heart can serve as its own 
control s
Material and methods 
Isolated heart preparation. The pig heart was chosen 
as the animal model because it shares many similarities 
with the human heart. 9-11 All animals received humane 
care in compliance with the "Guide to the Care and Use 
of Experimental Animals" (first edition) formulated by 
the Canadian Council on Animal Care and the protocols 
were approved by the National Research Council Canada 
Animal Care Committee. 
Domestic pigs that weighed 20 to 30 kg each were 
sedated with an intramuscular injection of diazepam (5 to 
10 rag) and ketamine (25 mg). Anesthesia was maintained 
with 1% halothane in O2/N2 after tracheotomy. The 
respiratory rate and volume were adjusted to keep the 
arterial blood gas levels within the normal physiologic 
range. The brachiocephalic artery was cannulated at the 
level of the common carotid artery for arterial pressure 
monitoring, blood sampling, and infusion of cardioplegic 
solution. 
A sternotomy was done. The brachiocephalic and sub- 
clavian arteries were dissected. The pericardium was 
opened longitudinally along the midline. The ascending 
aorta and the main pulmonary artery were isolated by 
threading umbilical tape around the origin of the descend- 
ing aorta. Anticoagulation was provided by injection of 
heparin (3000 IU) into the superior vena cava. A cannula 
was inserted centrally in the brachiocephalic artery. The 
brachiocephalic artery, subclavian artery, and superior 
and inferior venae cavae were then clamped in succession. 
The descending aorta was clamped, and heparinized cold 
cardioplegic solution (10 ° C) was infused (10 ml/kg body 
weight) into the aortic root via the brachiocephalic arte- 
rial cannula. The right and left atria were cut to allow 
drainage of the cardioplegic solution and to prevent he 
warm blood in the lungs from returning to the heart. Cold 
Krebs-Henseleit (K-H) solution was used for topical 
hypothermia in the chest cavity because pig blood was 
collected for perfusing the heart. 
The heart was then excised and immersed in cold 
cardioplegic solution. The brachiocephalic artery was 
joined to a cannula to be connected to a Langendorff 
perfusion apparatus. To measure left ventricular pressure 
a latex balloon was fixed in the left ventricle with a 
purse-string suture placed in the mitral valve and tied 
around the balloon mounting plug. Accumulation of 
blood in the left ventricle from thebesian flow was pre- 
vented by use of a small length of polyethylene. 
A small glass ball filled with phenyl phosphonic acid was 
inserted into the right ventricle as a reference for the 
31P-NMR signal intensities. Afterwards, hearts were 
placed in the magnet and perfused in the Langendorff 
apparatus (Fig. 1). The perfusion pressure was set at 
about 70 mm Hg at the beginning of the experiment and 
the corresponding flow rate was maintained throughout 
the protocol. It took approximately 20 minutes from 
cardiac in vivo arrest o reestablishment of coronary blood 
flow. Our previous studies showed that 20 minutes of 
ischemia t 12°C resulted in about a 20% decrease in 
phosphocreatine levels without notable alteration of ATP 
levels, which suggests that cardiac in vivo arrest during 
model preparation may not have a substantial impact on 
high energy phosphate stores. 12 
The temperatures of the pig hearts were maintained at 
37 ° -+ 0.5 ° C throughout the experiment. 
Perfusion solutions. During the control perfusion and 
reperfusion periods, the pig hearts were perfused with a 
mixture of autogenous blood and modified K-H solu- 
tion (1:1, vol/vol) such that the hematocrit level was 
12% to 15%. K-H solution had the following composi- 
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Fig. 1. Schematic representation f perfusion apparatus. Heart chamber, Shiley heater and bubble trap, 
and reservoirs are also connected to water bath for temperature control. 1, Heart; 2, heart chamber with 
nuclear magnetic resonance coil; 3, Shiley heater and air bubble trap; 4, roller pump; 5, reservoir; 6, 
oxygenator; 7,pressure transducer; 02 blood, oxygenated blood; de-O 2 blood, deoxygenated blood. 
tion: NaCl 118 mmol/L, KC1 4.7 mmol/L, MgSO 4 1.2 
mmol/L, glucose 11 mmol/I,, NaHCO 3 25 mmol/L, CaC12 
1.75 mmol/L, ethylenediaminetetraacetic acid 0.5 mmol/L, 
KH2PO 4 1.2 mmol/L,dextran 2%, and bovine serum 
albumin 0.5%. The mixture was bubbled vigorously with a 
95% 02:5% CO2 gas mixture to a final pH of 7.5. 
Cardioplegic arrest was done with a 16 mmol/L K ÷ 
mixture of autogenous blood and K-H solution with a 
hematocrit level of 12% to 15%. 
Assessment of contractile function. Heart rate, left 
ventricular developed pressure (left ventricular peak pres- 
sure minus end-diastolic pressure), and maximal rate of 
pressure increase (+dP/dt) and decrease (-dP/dt) were 
continuously recorded from a left ventricular balloon by 
means of a pressure transducer (model P23XL, Spec- 
tramed Inc., Oxnard, Calif.) during control perfusion and 
reperfusion with use of an electroencephalogram nd 
polygraph data recording system (Grass model 79E, Grass 
Instrument Co., Quincy, Mass.). Contractile function was 
also assessed by calculating the product of developed 
pressure and heart rate to give the rate-pressure product. 
Nuclear magnetic resonance spectroscopy. 31P-NMR 
spectroscopy was done at 4.7 T on a Biospec spectrometer 
(Bruker, Karlsruhe, Germany) with a 40 cm horizontal 
bore magnet operating at a phosphorus frequency of 81.03 
MHz. A home-built solenoid coil that surrounded the 
whole heart was used. Magnetic field homogeneity in the 
sample region was optimized by shimming on the sodium 
signal of the sample. Free induction decay (FID) signals 
were obtained by use of 4 K data points (10 K sweep 
width) and 45 ° radio frequency single hard pulses. The 
pulse length and repetition time were 80 /zsec and 1.5 
seconds, respectively. Eighty FID signals were accumu- 
lated for each spectrum according to protocol. Thus each 
nuclear magnetic resonance spectrum was averaged over a 
2-minute sample time. Accumulated FID signals were 
exponentially multiplied, resulting in 20 Hz line broaden- 
ing, to improve the signal-to-noise ratio. 
The observed phosphorus compounds included inor- 
ganic phosphate, phosphocreatine, and three peaks of 
ATP (c~, /3, and 3' peaks). The /3 peak was used for 
quantifying ATP. Because absolute quantification of me- 
tabolites observed by nuclear magnetic resonance in a 
perfused organ is difficult, spectral data were xpressed as 
the percentage of the initial ATP value that was obtained 
during control perfusion and set at 100%. Intracellular pH 
was calculated according to the chemical shift of the 
inorganic phosphate peak. 13 
Protocol. Pig hearts were divided into three groups. 
After 30 minutes of control perfusion, hearts in group 1 
(n = 10) were subjected to 90 minutes of continuous warm 
blood cardioplegia nd hearts from group 2 (n = 9) 
underwent 90 minutes of intermittent warm blood cardio- 
plegia, which consisted of six 10-minute episodes of 
ischemia (37 ° C) and six 5-minute periods of warm blood 
cardioplegia. After 90 minutes of "crossclamping," the 
hearts were then reperfused for 30 minutes. Hearts in 
group 3 (n = 4) were subjected to 150 minutes of blood 
perfusion as controls. 
Statistical analyses. Statistical analyses were done with 
STATGRAPHIC version 5 software (STSC, Inc., Rock- 
ville, Md.). All results were expressed as the mean plus or 
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Fig. 2. Representative 31P-NMR spectra obtained during infusion of warm blood cardioplegia nd 
subsequent interruptions. Observed phosphorus compounds i clude inorganic phosphate (Pi), phospho- 
creatine (PCr), and three peaks of ATP. Cardioplegic interruptions resulted in a significant decrease in 
phosphocreatine and increase in inorganic phosphate peaks. Recovery of phosphocreatine and inorganic 
phosphate l vels occurred during subsequent cardioplegic perfusion. 
minus standard error of the mean. A significant change in 
the level of phosphocreatine, inorganic phosphate, or 
intracellular pH during the period of intermittent cardio- 
plegia was determined by use of one-way analysis of 
variance (ANOVA). In other words, ANOVA was used to 
determine whether or not intermittent warm blood car- 
dioplegia would cause cumulative changes i  phosphocre- 
atine, inorganic phosphate, or intracellular pH. One-way 
ANOVA was also used to compare the values of ATP, 
phosphocreatine, and inorganic phosphate at the end of 
reperfusion among the three groups. Comparisons of 
contractile function among the three groups of hearts 
were made by one-way ANOVA with repeated measures. 
A significant difference was said to exist at a probability 
value of less than 0.05. 
Resu l ts  
Effect of intermittent warm blood cardioplegia 
on myocardial energy phosphates. Representative 
spectra obtained from a heart subjected to intermit- 
tent warm blood cardioplegia re shown in Fig. 2. 
It is deal that interruption of cardioplegia resulted 
in a significant decrease in the intensity of the 
phosphocreatine peak with a corresponding in- 
crease in the inorganic phosphate peak. However, 
phosphocreatine and inorganic phosphate l vels re- 
turned to normal during subsequent cardioplegic 
infusion. The changes in ATP, phosphocreatine, and 
inorganic phosphate l vels obtained from the hearts 
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Fig. 3. Time course of levels of myocardial ATP, phosphocreatine (PCr), and inorganic phosphate (Pi) 
from pig hearts during control perfusion, intermittent warm blood cardioplegia, nd repeffusion. Data are 
presented as means plus or minus standard e ror of means. 
Table I. Effect of intermittent warm blood cardioplegia on intracellular pH and phosphocreatine and inorganic 
phosphate levels 
Before End of each interruption 
cardioplegia 1 2 3 4 5 6 Reperfusion 
pHi 7.22 -+ 0.02 7.10 -+ 0.03 7.13 -+ 0.02 7.12 -+ 0.03 7.10 -+ 0.04 7.10 + 0.03 7.10 +- 0.04 7.20 + 0.03 
PCr (%) 230 + 10 128 -+12 122 -+ 8.2 115 _+ 9.1 118 - 7.7 119 _+ 10 119 - 10 265 + 12 
Pi (%) 70.2 + 4 131 - 9 136 _+ 7 144 -+ 11 141 + 6 143 +_ 8 147 + 7 80 _+ 4 
pHi, Intracellular pH; PCr, phosphocreatine; Pi, inorganic phosphate. PCr 
subjected to intermittent warm blood cardioplegia 
are summarized in Fig. 3. ATP levels decreased 
slightly during 90 minutes of intermittent cardiople- 
gia and recovered completely during reperfusion. 
Each interruption resulted in a large decrease in the 
phosphocreatine l vel and corresponding rise in 
inorganic phosphate l vel, whereas ubsequent car- 
dioplegic infusion resulted in complete recovery of 
the phosphocreatine and inorganic phosphate lev- 
els. The average values of phosphocreatine and 
inorganic phosphate obtained from nine hearts dur- 
ing control perfusion, reperfusion, a d six interrup- 
tions are presented in Table I. Phosphocreatine 
level was 230% -+ 10.3% and 265% +_ 12.7% during 
control perfusion and reperfusion, respectively. In- 
and Pi are expressed as percent of i i ial ATP level (/3-peak). 
termittent warm blood cardioplegia resulted in a 
significant drop in phosphocreatine level (p < 0.01). 
However, there were no significant differences (p > 
0.05) between phosphocreatine values measured 
during the six interruptions. Moreover, although 
inorganic phosphate levels increased significantly 
(p < 0.01) during each interruption, the differences 
at the end of each of the six interruptions were not 
statistically significant (p > 0.05). The results sug- 
gested that under our experimental conditions in- 
termittent warm blood cardioplegia did not result in 
a cumulative loss of phosphocreatine or gain in 
inorganic phosphate. 
Comparisons of ATP, phosphocreatine, and inor- 
ganic phosphate l vels measured throughout exper- 
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Fig. 4. Time course of levels of myocardial ATP, phos- 
phocreatine (PCr), and inorganic phosphate (Pi) obtained 
from three groups of hearts throughout protocol. Data are 
presented as means plus or minus standard error of 
means. 
iments from the three groups of hearts are pre- 
sented in Fig. 4. One-way analyses of variance with 
repeated measures demonstrated that there were no 
significant differences in ATP levels among the 
three groups. The differences in phosphocreatine 
levels at the end of reperfusion were not statistically 
significant. The level of inorganic phosphate in the 
hearts that underwent continuous warm blood car- 
7.3" 
7.2  " 
7.1 
7.0 ¸  
6.9 I ! ! ! s ! I 
0 1 2 3 4 5 6 7 
Number of the Interruption 
Fig. 5. Intracellular pH measured at the end of six 10- 
minute ischemic episodes. Data are presented as means 
plus or minus standard error of means (n = 9). 
dioplegia was significantly higher than that in the 
hearts subjected to intermittent warm blood cardio- 
plegia or control perfusion, which might be indica- 
tive of myocardial edema caused by continuous 
delivery of blood cardioplegia. 
Effect of intermittent warm blood carflioplegia on 
intracellular pH. Intracellular pH during control 
perfusion, intermittent cardioplegia, and reperfu- 
sion is shown in Fig. 5 and Table I. Under our 
experimental conditions, intracellular pH during 
control perfusion and reperfusion was 7.22 _ 0.02 
and 7.20 _+ 0.03, respectively. The difference in pH 
between control perfusion and reperfusion was not 
significant (p > 0.05). A 10-minute interruption of 
warm blood cardioplegia resulted in an average 
decrease in intracellular pH by 0.12 unit. Subse- 
quent interruptions did not result in further de- 
creases in intracellular pH because there were no 
significant differences in intracellular pH at the end 
of each interruption (p > 0.05). 
Effect of intermittent warm blood cardioplegia on 
functional recovery during reperfusion. Compari- 
sons of the rate-pressure product and + dP/dt during 
reperfusion among the three groups of pig hearts 
are shown in Fig. 6. There were no significant 
differences in these parameters between the hearts 
subjected to either intermittent or continuous warm 
blood cardioplegia, which suggests that intermittent 
warm blood cardioplegia did not worsen myocardial 
contractile function. 
Discussion 
This study showed that a 10-minute interruption 
of warm blood cardioplegia resulted in decreases in 
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myocardial phosphocreatine levels and intracellular 
pH by 45% (p < 0.01) and 0.12 unit (p < 0.05), 
respectively, and an increase in inorganic phosphate 
levels by 88%, compared with their preischemic 
values. Five subsequent interruptions lasting 10 min- 
utes each did not cause cumulative changes of these 
parameters. Furthermore, there were no significant 
differences in levels of myocardial energy metabo- 
lites (ATP, phosphocreatine, and inorganic phos- 
phate), intracellular pH, or contractile function dur- 
ing reperfusion in the hearts that underwent either 
intermittent or continuous warm blood cardioplegia. 
The results suggest hat intermittent warm blood 
cardioplegia with 10-minute ischemic intervals 
caused mild ischemic hanges and these alterations 
were not cumulative, which indicates that warm 
blood cardioplegia may be safely interrupted in the 
normal heart for surgical precision without causing 
myocardial ischemic injury. 
According to the levels of high energy phos- 
phates, reversible myocardial ischemia has been 
arbitrarily divided into three phases: latency, sur- 
vival time, and revival time) 4 During the first period 
of ischemia there are essentially no changes in the 
levels of ATP, phosphocreatine, or inorganic phos- 
phate: oxidative phosphorylation is still the major 
energy source for maintenance of function and 
structure of the myocyte by using oxygen remaining 
in the myocardium in the form of oxymyoglobin, 
oxyhemoglobin, and physically dissolved oxygen. 
Myocardial oxygen consumption i the normal beat- 
ing heart is about 10 ml/min per 100 gm tissue and 
the oxygen reserve in the myocardium at the onset 
of ischemia is about 1 to 2 ml/100 gm tissue. The 
latency period initiated by stopping coronary flow in 
the heart subjected to normothermic schemia will 
last only 1 to 20 seconds. This period will be 
significantly prolonged in the cardioplegically ar- 
rested heart because oxygen consumption has been 
significantly reduced, from 10 to 1 ml/min per 100 
gm. 14 As a result, the latency period in the heart 
subjected to intermittent warm blood cardioplegia s
about I to 2 minutes. During this period, myocardial 
metabolism, structure, and function remain essen- 
tially unchanged. 
During the second phase of ischemia (survival 
time), phosphocreatine is used to replenish ATP 
stores in the cytoplasm, which leads to a decrease in 
phosphocreatine l vel, accompanied by a rise in 
inorganic phosphate. This period ends when the 
phosphocreatine level decreases to 40% of its nor- 
mal value and lasts about 1 to 3 minutes in the 
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Fig. 6. Comparison of rate-pressure product (RPP) and 
+ dP/dt between pig hearts subjected to either continuous 
or intermittent warm blood cardioplegia or 150 minutes of 
control perfusion. 
nonarrested heart. In contrast, Table I and Fig. 3 
show that it took about 10 minutes for phosphocre- 
atine levels to decrease to a similar level in the 
arrested hearts, which indicates that intermittent 
warm blood cardioplegia with 10-minute ischemic 
intervals resulted in only mild ischemic hanges. 
Additionally, one important effect of ischemia is 
the generation of protons derived from anaerobic 
glycolysis with breakdown of ATP and from other 
metabolic ycles that form protons, leading to a 
decrease in tissue pH. 15 The severity of ischemic 
injury has been shown to be related to the extent of 
pH decrease) 6 Accumulation of protons can cause 
influx of Na + and Ca + + via Na+'/H + and Na+/Ca + + 
exchange. More important, a fall in intracellular pH 
inhibits the activity of phosphofructokinase and 
consequently decreases energy production during 
ischemia. 15 It has been proposed that pH is an 
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important factor in determining the difference be- 
tween the ffects of severe ischemia, which inhibits 
glycolysis, and mild ischemia, which accelerates gly- 
colysis) 5Conceivably, tissue pH is an important and 
reliable metabolic indicator of the magnitude of 
ischemic injury and of the adequacy of myocardial 
protection. The transition from mild acidosis to 
severe acidosis is rather arbitrary. It is generally 
accepted that intracellular pH below 6.2 represents 
severe acidosis) 3 In the present study, a 10-minute 
interruption of warm blood cardioplegia resulted in 
an intracellular pH decrease of only 0.12 unit (from 
a control value of 7.22 to 7.10) and subsequent 
interruptions did not cause further pH decreases 
(Table I). The intracellular pH at the end of each 
interruption remains within the normal physiologic 
range (Table I). Combined with the changes in the 
levels of myocardial phosphocreatine and inorganic 
phosphate, our results indicate that interruption of 
warm blood cardioplegia for 10 minutes repeated six 
times results in mild alterations in myocardial met- 
abolic homeostasis, which soon recovers on resump- 
tion of coronary flow. 
In addition, it is well known that reperfusion is not 
always fully beneficial although it is an absolute pre- 
requisite for survival of the ischemic myocardium) 7-19 
Under certain circumstances, reperfusion can result in 
additional deleterious effects in the ischemic myocar- 
dium) 7~9 A group of unwanted events consequent to
reperfusion is defined as reperfusion injury, and the 
magnitude of reperfusion injury is closely related to 
the severity of ischemic injury. 17-19 As mentioned 
previously, the ischemic changes induced by six 10- 
minute interruptions ofwarm blood cardioplegia were 
mild and may not be sufficient o impose any signifi- 
cant damage on the myocardium. Under these condi- 
tions, recurrent restoration of cardioplegia may not 
cause any detrimental effect. 
In addition, it has been documented that intracel- 
lular Ca ++ overload is a critical mechanism respon- 
sible for reperfusion i jury. 17-19 This Ca ++ overload 
is, to a great extent, caused by a preceding ischemia- 
induced Na + overload and by disruption of the 
sarcolemmal structure and dysfunction of the sarco- 
plasmic reticulum. Because the free energy of ATP 
hydrolysis (AGATP) is normally about 15 to 20 
kilojoules per mole greater than the energy equired 
to drive the Na+/K + pump and the decreases in 
ATP and intracellular pH during intermittent warm 
i~lood cardioplegia were small, the pump kinetics 
were not expected to be limited, z° Thus intracellular 
Na + would not increase significantly during inter- 
mittent warm blood cardioplegia lthough we did 
not measure intracellular Na + during the course of 
our experiments. Therefore recurrent restoration of 
cardioplegia would not be expected to result in any 
increase in the level of intracellular Ca ++. Further- 
more, cardioplegia bolishes the action potential 
and inactivates myocardial Na + and Ca ++ chan- 
nels. 14 This suggests that recurrent cardioplegia in 
our experimental pattern may not result in signifi- 
cant reperfusion injury. This was supported by our 
finding that hearts subjected to intermittent warm 
blood cardioplegia showed recovery of contractile 
function similar to that in those subjected to contin- 
uous cardioplegia. 
Although ischemic metabolic alterations caused 
by intermittent warm blood cardioplegia were insub- 
stantial and intermittent warm blood cardioplegia 
seemed to provide myocardial protection equal to 
that of continuous warm blood cardioplegia under 
our experimental conditions, we still do not know 
whether intermittent warm blood cardioplegia dam- 
ages endothelial cells. In addition, 31p-NMR spec- 
troscopy as used in this study provided only average 
values of energy metabolites and intracellular pH 
over the whole heart. It may be possible that some 
part of the myocardium was damaged (at a level 
below the detection sensitivity of our instrument) by 
interruption of warm blood cardioplegia because the 
myocardium in various parts of the heart may differ 
in susceptibility o ischemic insult. Additionally, the 
flow rate of intermittent cardioplegia is another 
important element in determining the efficacy or 
safety of intermittent warm blood cardioplegia be- 
cause the distribution of cardioplegia solution be- 
tween the subendocardium and the subepicardium 
can depend on the flow rate. 
This study examined normal hearts of pigs that 
were perfused antegradely. Therefore the results 
obtained cannot be directly extrapolated to human 
hearts with significant coronary artery disease or 
hypertrophy. In addition, interruption of retrograde 
normothermic cardioplegia may have different con- 
sequences than interruption of antegrade normo- 
thermic cardioplegia. Furthermore, in situ hearts 
have noncoronary collateral flow that does not exist 
in the isolated heart preparation used in our studies. 
In conclusion, intermittent warm blood cardioplegia 
under our experimental conditions did not result in 
a cumulative severe ischemic injury and seemed to 
provide "equal" protection to that of continuous blood 
cardioplegia. However, its effect on the diseased and in 
situ heart requires further investigation. 
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